Corbus Pharmaceuticals
CRBP
CRBP
69 hedge funds and large institutions have $109M invested in Corbus Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
0.05% less ownership
Funds ownership: 1.06% → 1.01% (-0.05%)
34% less call options, than puts
Call options by funds: $1.58M | Put options by funds: $2.37M
Holders
69
Holding in Top 10
1
Calls
$1.58M
Puts
$2.37M
Top Buyers
| 1 | +$1.14M | |
| 2 | +$1.14M | |
| 3 | +$1.01M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$633K |
| 5 |
State Street
Boston,
Massachusetts
|
+$552K |
Top Sellers
| 1 | -$5.85M | |
| 2 | -$1.22M | |
| 3 | -$1.19M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$820K |
| 5 |
AG
Artal Group
Luxembourg
|
-$715K |